| FORMYCON AG |
| Deutschland |
| Gesundheit |
| DE000A1EWVY8 / A1EWVY |
| FYB (Frankfurt) |
| FRA:FYB, ETR:FYB, FYB:GR |
| SDAX |
| https://www.formycon.com/ |
|
Formycon AG is an innovative, science-driven pharm..
>Volltext.. |
| 417.82 Mio. EUR |
| 400.75 Mio. EUR |
| 51.95 Mio. EUR |
| -14.24 Mio. EUR |
| -170.34 Mio. EUR |
| -9.64 EUR |
| 10.24 Mio. EUR |
| 27.37 Mio. EUR |
| 14.72 Mio. EUR |
| 0.67 |
| -14.84% |
| -365.69% |
| - |
| - |
| - |
| - |
| FORMYCON, NANOHALE |
| 16.12.25 |